Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients

Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients

Background/Aims Oral mesalazine is an important treatment for ulcerative colitis (UC), and non-adherence to mesalazine increases the risk of relapse. Controlled-release (CR) mesalazine has 2 formulations: tablets and granules. The relative acceptabilities of these formulations may influence patient...

Full description

Bibliographic Details
Main Authors: Keiji Yagisawa, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Takahiko Toyonaga, Miki Miura, Mari Hayashida, Eiko Saito, Masaru Nakano, Hajime Matsubara, Tadakazu Hisamatsu, Toshifumi Hibi
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2019-01-01
Series:Intestinal Research
Subjects:
Colitis, ulcerative
Mesalamine
Medication adherence
Patient acceptance of health care
Drug compounding
Online Access:http://www.irjournal.org/upload/pdf/ir-2018-00078.pdf

Internet

http://www.irjournal.org/upload/pdf/ir-2018-00078.pdf

Similar Items